Prognostic value of a modified systemic inflammation score in breast cancer patients who underwent neoadjuvant chemotherapy.

Jiang, Cong; Xiu, Yuting; Yu, Xiao; Qiao, Kun; Zhang, Shiyuan; Huang, Yuanxi

Jiang, Cong; Xiu, Yuting; Yu, Xiao; Qiao, Kun; Zhang, Shiyuan; Huang, Yuanxi.

Afiliação

Jiang C; Department of Breast Surgery, Harbin Medical University Cancer Hospital, Harbin, China.
Xiu Y; Department of Breast Surgery, Harbin Medical University Cancer Hospital, Harbin, China.
Yu X; Department of Breast Surgery, Harbin Medical University Cancer Hospital, Harbin, China.
Qiao K; Department of Breast Surgery, Harbin Medical University Cancer Hospital, Harbin, China.
Zhang S; Department of Breast Surgery, Harbin Medical University Cancer Hospital, Harbin, China. hmu_zsy@163.com.
Huang Y; Department of Breast Surgery, Harbin Medical University Cancer Hospital, Harbin, China. rxwk@163.com.

BMC Cancer ; 22(1): 1249, 2022 Dec 02.

Article em En | MEDLINE | ID: mdl-36460981

Assuntos

Neoplasias Inflamatórias Mamárias; Terapia Neoadjuvante; Humanos; Prognóstico; Estudos Retrospectivos; Neoplasias Inflamatórias Mamárias/tratamento farmacológico; Inflamação; Albuminas

Palavras-chave

Breast cancer; Interaction; Nomogram; mSIS

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Terapia Neoadjuvante / Neoplasias Inflamatórias Mamárias Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google